Clinical Psychiatry NewsIV ketamine, intranasal esketamine likely to ‘happily coexist’March 6, 2019Depression
Clinical Psychiatry NewsFDA approves intranasal esketamine for refractory major depressive disorderMarch 5, 2019Depression
Clinical Psychiatry NewsScott Gottlieb to step down as FDA commissionerMarch 5, 2019Business of Medicine
Clinical Psychiatry NewsBehavioral intervention improves physical activity in patients with diabetesMarch 5, 2019Depression
Clinical Psychiatry NewsDrug pricing does not inspire Americans’ trustMarch 5, 2019Business of Medicine
Clinical Psychiatry NewsSupplements and food-related therapy do not prevent depression in overweight adultsMarch 5, 2019Depression
